Literature DB >> 3414825

Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats.

J S Gutkind1, M Kurihara, J M Saavedra.   

Abstract

We analyzed angiotensin II (ANG II) receptors by in vitro autoradiography in selective brain nuclei of control, salt-treated (1% NaCl in drinking water), deoxycorticosterone acetate (DOCA)-treated (DOCA pivalate, 25 mg/kg sc weekly), and DOCA-salt-treated (DOCA + salt treatments) uninephrectomized male Wistar-Kyoto rats. After 4 wk of treatment, only the DOCA-salt group developed hypertension. ANG II binding increased in median preoptic nucleus and subfornical organ of salt- and DOCA-treated rats. DOCA-treated rats also showed increased ANG II binding in paraventricular nucleus. DOCA-salt-treated rats showed higher ANG II binding in nucleus of the solitary tract and area postrema, as well as in the areas mentioned before. Although salt and/or DOCA treatments alone increased ANG II receptors in some brain nuclei, after combined DOCA-salt treatment there was significantly higher ANG II binding in all areas, except the median preoptic nucleus. These results suggest that increased ANG II receptors in selected brain areas may play a role in the pathophysiology of mineralocorticoid-salt experimental hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3414825     DOI: 10.1152/ajpheart.1988.255.3.H646

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

3.  A haplotype of angiotensin receptor type 1 associated with human hypertension increases blood pressure in transgenic mice.

Authors:  Sudhir Jain; Alicia Prater; Varunkumar Pandey; Anita Rana; Nitin Puri; Ashok Kumar
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Richter and sodium appetite: from adrenalectomy to molecular biology.

Authors:  Eric G Krause; Randall R Sakai
Journal:  Appetite       Date:  2007-04-11       Impact factor: 3.868

Review 5.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

6.  Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice.

Authors:  Justin L Grobe; Beth A Buehrer; Aline M Hilzendeger; Xuebo Liu; Deborah R Davis; Di Xu; Curt D Sigmund
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

7.  Effect of tryptophan and 5-hydroxytryptophan on the blood pressure of patients with mild to moderate hypertension.

Authors:  J R Cade; M J Fregly; M Privette
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

8.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

9.  Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats.

Authors:  Hongwei Li; Yongxin Gao; Yanfei Qi; Michael J Katovich; Nan Jiang; Leah N Braseth; Deborah A Scheuer; Peng Shi; Colin Sumners
Journal:  FASEB J       Date:  2008-06-05       Impact factor: 5.191

10.  Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.

Authors:  Aline M Hilzendeger; Martin D Cassell; Deborah R Davis; Harald M Stauss; Allyn L Mark; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2012-12-24       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.